Bacterial Diseases
Bacterial Diseases(细菌性疾病)
Bacterial Diseases 相关产品(602)
- GC48489Cefadroxil-d4 (trifluoroacetate salt)CAS: 1426215-61-3纯度: >99.00%
An internal standard for the quantification of cefadroxil
- GC48516Nafcillin-d5 (sodium salt)CAS: 1356354-25-0纯度: >99.00%
An internal standard for the quantification of nafcillin
- GC48528Piericidin BCAS: 16891-54-6纯度: >98.00%
A bacterial metabolite with insecticidal and antimicrobial activities
- GC48565Ofloxacin-d8 (hydrochloride)CAS: 2930288-81-4纯度: >99.00%
An internal standard for the quantification of ofloxacin
- GC48580Penicolinate BCAS: 1418291-70-9纯度: >95.00%
A fungal metabolite with diverse biological activities
- GC48593Cefprozil-d4CAS: 1426173-48-9纯度: >99.00%
An internal standard for the quantification of cefprozil
- GC48642Tedizolid-13C-d3CAS: 2931763-72-1纯度: >99.00%
An internal standard for the quantification of tedizolid
- GC48664Enoxacin-d8 (hydrochloride)CAS: 2930288-95-0纯度: >99.00%
An internal standard for the quantification of enoxacin
- GC48693Rubiginone D2CAS: 274913-71-2纯度: >95.00%
A polyketide with antibacterial and anticancer activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC48443 | Cefsulodin (sodium salt hydrate) | 1426397-23-0 | >95.00% | |
A cephalosporin antibiotic | ||||
| GC48445 | Hygromycin B (hydrate) | - | >85.00% | |
An aminoglycoside antibiotic | ||||
| GC48457 | 3-keto Fusidic Acid | 4680-37-9 | >95.00% | |
An active metabolite of fusidic acid | ||||
| GC48472 | Aranciamycin A | 960622-70-2 | >95.00% | |
An antibiotic | ||||
| GC48489 | Cefadroxil-d4 (trifluoroacetate salt) | 1426215-61-3 | >99.00% | |
An internal standard for the quantification of cefadroxil | ||||
| GC48501 | Preterramide C | 81469-77-4 | >95.00% | |
A fungal metabolite | ||||
| GC48504 | Betulinic Aldehyde oxime | 25613-12-1 | >95.00% | |
A derivative of betulin | ||||
| GC48511 | Avrainvillamide | 269741-97-1 | >95.00% | |
A fungal metabolite | ||||
| GC48516 | Nafcillin-d5 (sodium salt) | 1356354-25-0 | >99.00% | |
An internal standard for the quantification of nafcillin | ||||
| GC48523 | HSGN-218 | 2519410-44-5 | >98.00% | |
A gut-restrictive antibiotic | ||||
| GC48528 | Piericidin B | 16891-54-6 | >98.00% | |
A bacterial metabolite with insecticidal and antimicrobial activities | ||||
| GC48546 | Emeguisin A | 117032-54-9 | >95.00% | |
A fungal metabolite | ||||
| GC48547 | Sartorypyrone D | 1801167-48-5 | >95.00% | |
A fungal metabolite | ||||
| GC48554 | Isoreserpiline | 572-67-8 | >95.00% | |
An indole alkaloid with diverse biological activities | ||||
| GC48565 | Ofloxacin-d8 (hydrochloride) | 2930288-81-4 | >99.00% | |
An internal standard for the quantification of ofloxacin | ||||
| GC48580 | Penicolinate B | 1418291-70-9 | >95.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC48593 | Cefprozil-d4 | 1426173-48-9 | >99.00% | |
An internal standard for the quantification of cefprozil | ||||
| GC48619 | Nanangenine B | 1609469-72-8 | >95.00% | |
A drimane sesquiterpene | ||||
| GC48642 | Tedizolid-13C-d3 | 2931763-72-1 | >99.00% | |
An internal standard for the quantification of tedizolid | ||||
| GC48660 | Nanangenine F | - | >95.00% | |
A drimane sesquiterpene | ||||
| GC48664 | Enoxacin-d8 (hydrochloride) | 2930288-95-0 | >99.00% | |
An internal standard for the quantification of enoxacin | ||||
| GC48667 | Nanangenine C | - | >95.00% | |
A drimane sesquiterpene | ||||
| GC48684 | Pipemidic Acid (hydrate) | 72571-82-5 | >98.00% | |
An antibiotic | ||||
| GC48693 | Rubiginone D2 | 274913-71-2 | >95.00% | |
A polyketide with antibacterial and anticancer activities | ||||